Mahamaya Lifesciences IPO Allotment Status: How to Check & Latest GMP Updates

Mahamaya Lifesciences IPO – Key Details

ItemDetails
Price Band₹108 – ₹114 per share
Issue SizeApprox. ₹70.44 crore
Lot Size2,400 shares (minimum for retail)
Subscription WindowNovember 11 – 13, 2025
Basis of AllotmentNovember 14, 2025 (expected)
Listing DateNovember 18, 2025 (on BSE SME platform)

Subscription & GMP Snapshot

CategorySubscription (approx.)
QIBs~1.19×
NIIs~2.95×
Retail~1.02×
Overall Subscription~1.59×
MetricValue
Grey Market Premium (GMP)~₹0 per share (flat)
Estimated Listing vs Price BandNear issue price (no premium)

Interpretation:
Subscription appears decent overall, especially in NII category. However, the GMP being flat suggests market anticipates the listing price will be close to the issue price — i.e., limited listing pop.

How to Check Your Allotment Status

Option 1: Registrar (KFin Technologies Ltd)

  1. Visit the IPO allotment status page of KFin.
  2. Select “Mahamaya Lifesciences Ltd” from the company list.
  3. Enter your PAN, Application Number, or DP-Client ID.
  4. Submit and view the allotment outcome.

Option 2: Through Stock Exchange Platform (e.g., BSE Limited)

  1. Go to the “Status of Issue Application” page.
  2. Choose Issue Type: Equity, and select Mahamaya Lifesciences Ltd IPO.
  3. Enter your PAN or Application Number.
  4. Click Search — you’ll see if shares were allotted or not.

Option 3: Via Your Demat/Trading Account

  • After the allotment date, log into your demat/trading account.
  • Check if shares of Mahamaya Lifesciences appear in your holdings.
  • If not appeared but refund credited → likely not allotted.

Quick Recap

  • Allotment expected: Nov 14, 2025.
  • Overall subscription ~ 1.59×.
  • GMP: ~ ₹0 → indicates expected listing close to issue price.
  • Listing date: Nov 18, 2025 on BSE SME.

Disclaimer

The stocks mentioned in this article are not recommendations. Please conduct your own research and due diligence before investing. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please read the Risk Disclosure documents carefully before investing in Equity Shares, Derivatives, Mutual fund, and/or other instruments traded on the Stock Exchanges. As investments are subject to market risks and price fluctuation risk, there is no assurance or guarantee that the investment objectives shall be achieved. Lemonn (Formerly known as NU Investors Technologies Pvt. Ltd) do not guarantee any assured returns on any investments. Past performance of securities/instruments is not indicative of their future performance.